There has been an increase in demand for Zika virus tests due to improved methods used in the medical field to detect and control outbreaks that result from infections. Zika virus, which is spread mainly through mosquito bites, is a major threat from the standpoint of public health issues, especially considering that Zika virus infection may lead to congenital abnormalities.
To detect infections on time and provide patients with proper treatment, healthcare facilities implement advanced diagnostic methods for detecting diseases, such as Zika virus infections. Molecular, serological diagnostics, and fast testing kits are actively implemented in the modern healthcare system in various institutions such as hospitals and diagnostic laboratories.
The Zika Virus Testing Market size was estimated at USD 239.91 million in 2025 and is expected to reach USD 480.44 million by 2035, growing at a CAGR of 7.28% during the forecast period 2026–2035.
Leading Zika Virus Testing Companies Driving Market Competition:
Roche
Roche is the leading manufacturer of diagnostic solutions. This firm specializes in molecular tests for viruses. The company develops digital PCR based diagnostic solutions for accurate virus detection. Strong global presence enables this corporation to promote diagnostics across the globe. This corporation is continuously investing in automated and digital diagnostics solutions.
Abbott Laboratories
Abbott Laboratories manufactures a broad array of diagnostic solutions, from fast tests to molecular systems for diagnostics of infectious diseases. The products of this company can be used both in laboratories and for point-of-care diagnostics. Abbott Laboratories is continuously growing its presence in the field of global diagnostics. Its innovations in portable diagnostics increase effectiveness in case of outbreaks.
Thermo Fisher Scientific
The solutions offered by Thermo Fisher Scientific include PCR-based test systems. This corporation provides its customers with highly accurate diagnostics. Thermo Fisher Scientific is engaged in virus detection through research and diagnostics. This corporation is continuously making investments into innovations in molecular diagnostics.
Quest Diagnostics
is a major player in the provision of diagnostic information services. The firm has broad testing capabilities when it comes to providing diagnostic testing for infectious conditions, such as the Zika virus. Quest Diagnostics has a large laboratory facility that allows high volumes of testing. Diagnostic turnaround time and accuracy are among the focal areas at Quest Diagnostics.
ARUP Laboratories
ARUP Laboratories provides diagnostic services and research services for infectious diseases. The laboratory is engaged in specialized and innovative tests for infectious conditions. The laboratory has great experience in molecular diagnostic techniques that help in the identification of different viruses, including Zika. ARUP collaborates with other players in health care to advance diagnostic services.
Eurofins Scientific
Eurofins Scientific provides diverse services within laboratory testing. The firm is involved in providing diagnostics for several infections, such as the Zika virus. The company has laboratory facilities spread worldwide to offer high-quality services for clients. Eurofins is expanding its diagnostics service offerings.
Key Market Trends Driving Expansion in Zika Virus Testing:
Zika virus tests have mainly been influenced by the increased adoption of advanced molecular diagnostics and rapid test platforms. Medical facilities such as hospitals and diagnostic laboratories have been investing in diagnostic techniques that can detect viruses accurately while at the same time ensuring quick responses in the event of an outbreak.
Multiplex test kits as well as point-of-care tests are becoming popular since they provide fast results while at the same time allowing simultaneous diagnosis of different types of infections.
Portable PCR kits have also played a significant role in enhancing diagnostic practices.
There has also been an increase in the focus on surveillance and reporting systems that integrate data in real time.
Outlook: Innovation and the Next Phase of Zika Virus Diagnostics
There is a high likelihood that the Zika virus testing market will remain highly dynamic in the future due to innovations in technology and the global preparedness of countries. Manufacturers will continuously be working to create innovations in testing platforms and other aspects such as automation and portability of tests.
With the increasing risk of infectious disease outbreaks across the world, there is a need for increased investments and innovations to come up with improved testing platforms. Research and technological development in healthcare will greatly contribute to future growth in the industry.
Infectious disease diagnosis using Zika virus testing will always be necessary. Advancements in technology and increasing global awareness about the issue will drive growth within the market.
